This review summarizes the pharmacological management of atrial fibrillation, including rhythm control, rate control, and thromboembolism prophylaxis.
No takes yet. Share an insight, caveat, or question.
Supports clinician recall of AF regimens; leaves open refinement with contemporary agents and subgroups.
KS Channer (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: